If you would like clinician follow-up without returning for an in-person visit, Tonums research and telehealth resources can be a helpful next step
Prevention and reversal of ketamine-induced schizophrenia related behaviour by minocycline in mice: possible involvement of antioxidant and nitrergic pathway
Expanding weight-loss treatments The weight-loss industry remains divided over the broader applications and outcomes of obesity drugs beyond total weight reduction
They put it on a list called S0: "Non-Approved Substances." It is the category for things that no health authority, anywhere in the world, has approved for use in humans
It is often used for people with strong opioid addiction
Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, GHRP-2 vs Ipamorelin Cosmetic Peptide Comparison: BPC-157 vs TB-500, IGF-1 vs IGF-1 LR3, Semax vs Selank, and GHRP-2 vs Ipamorelin At a glance BPC-157 half-life / approximately 4 hours (subcutaneous or intramuscular) TB-500 half-life / longer systemic distribution, dosed 2-4 mg twice weekly IGF-1 LR3 active window / up to 20 hours vs ~20 minutes for native IGF-1 Semax mechanism / upregulates BDNF and dopamine receptor sensitivity Selank mechanism / enhances GABA-A tone and reduces IL-6 by ~30% in animal models GHRP-2 GH pulse / strong but co-elevates cortisol and prolactin Ipamorelin GH pulse / selective